IBB

Recent Articles

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is on Breakout Watch!

The iShares Nasdaq Biotechnology ETF (IBB) has settled into a constructive-looking phase. The path of least resistance? North! More 

Amgen, Inc (AMGN) – Amgen Stock Is a Powerhouse

Biotechs such as Amgen stock have been riding high for more than a month. AMGN in particular looks promising for new money. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) — It’s Make-or-Break Time

While the intermediate-term trend remains intact for the IBB etf, earnings season for large biotech companies could be make-or-break. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!

Active investors and traders should look to play the iShares Nasdaq Biotechnology Index (ETF) (IBB) to the short side until the picture changes. More 

Biotech Bloodbath: Ditch XBI, IBB for Now

Biotech ETFs IBB and XBI are in a hurt locker right now. Even if you're bullish on biotechs for the long-term, consider a hedge play or two for now. More 

IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy

Even if Hillary Clinton becomes the next POTUS, biotech stocks won't sink into oblivion -- that's enough reason to buy the IBB ETF. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB): Just Short It!

The biotech sector has had its ups and downs, but I think there are more downs to come. Short IBB for free. More